ClinicalTrials.Veeva

Menu

Effectiveness and Security Testing of a Mobile App

C

Consorci Sanitari del Maresme

Status

Begins enrollment in 7 months

Conditions

Attention Deficit Disorder With Hyperactivity

Treatments

Device: Mobile app
Combination Product: Treatment as usual

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

To assess the effectiveness and security of a mobile App (beta version) for self-managing emotion dysregulation in a pragmatic randomized controlled trial with 80 adolescents with attention-deficit/hyperactivity disorder comparing 40 patients with treatment as usual (TAU) with 40 patients with TAU plus the mobile App

Enrollment

80 estimated patients

Sex

All

Ages

14 to 17 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition) of attention-deficit/hyperactivity disorder
  • High emotion dysregulation severity
  • Aged 14 to 17 years
  • Outpatient setting (Consorci Sanitari del Maresme

Exclusion criteria

  • Comorbidity with mental retardation
  • Comorbidity with psychotic disorder
  • Comorbidity with autism spectrum disorder

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

80 participants in 2 patient groups

Treatment as usual plus mobile app
Experimental group
Description:
Those who will receive naturalistic treatment in outpatient setting and also the mobile app
Treatment:
Combination Product: Treatment as usual
Device: Mobile app
Treatment as usual
Active Comparator group
Description:
Those who will receive naturalistic treatment in outpatient setting but not the mobile app
Treatment:
Combination Product: Treatment as usual

Trial contacts and locations

0

Loading...

Central trial contact

Alvaro Frias

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems